e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
IIPs: orphan
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The clinical significance of 24hr continuous monitoring of SpO2 during daily life in the patients with interstitial pneumonia
Mitsuko Kondo (Tokyo, Japan), Mitsuko Kondo, Ken Arimura, Kiyoshi Takeyama, Etsuko Tagaya, Jun Tamaoki
Source:
International Congress 2015 – IIPs: orphan
Session:
IIPs: orphan
Session type:
Thematic Poster Session
Number:
3825
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mitsuko Kondo (Tokyo, Japan), Mitsuko Kondo, Ken Arimura, Kiyoshi Takeyama, Etsuko Tagaya, Jun Tamaoki. The clinical significance of 24hr continuous monitoring of SpO2 during daily life in the patients with interstitial pneumonia. Eur Respir J 2015; 46: Suppl. 59, 3825
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Static lung volumes and spirometry measurements
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the “HYPID” study
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013
PaO2/FiO2 with low PEEP using NPPV is a significant predictor on survival in acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Clinical experience with nintedanib for the treatment of IPF in 80 cases
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Effect of baseline FVC on lung function decline with nintedanib in patients with IPF
Source: International Congress 2015 – Treatment of IPF
Year: 2015
Longitudinal change in non-invasive markers in interstitial lung disease associated pulmonary hypertension and correlation with invasive pulmonary haemodynamics
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Non-invasive haemodynamic measurement to detect treatment response in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study
Source: Annual Congress 2013 –Pulmonary circulation: treatment
Year: 2013
Pulmonary hypertension in interstitial lung disease: Non-invasive assessment for detection and prognosis
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Pulmonary hypertension in patients with interstitial lung disease
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011
Hemodynamic assessment of patients with pulmonary hypertension due to lung disease and/or hypoxia
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
Noninvasive positive pressure ventilation in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: Annual Congress 2006 - Pulmonary fibrosis: pathophysiology and therapeutic approaches
Year: 2006
Effect of baseline corticosteroid medication on reduction in FVC decline with nintedanib
Source: International Congress 2015 – Treatment of IPF
Year: 2015
Effect of baseline composite physiologic index on benefit of nintedanib in IPF
Source: International Congress 2016 – IPF treatment I
Year: 2016
Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Scoring system predicting for elevation of MPAP in IPF
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Patterns of cardiopulmonary response to exercise in lung diseases
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-49-5, page=69
Year: 2007
Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Pulmonary vascular response patterns during exercise in interstitial lung disease (ILD)
Source: International Congress 2014 – Mechanisms of exercise limitation in disease
Year: 2014
Treatment of combined pulmonary fibrosis and emphysema
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Non-invasive ventilation in the management of acute respiratory failure in patients with idiopathic pulmonary fibrosis
Source: International Congress 2014 – Expanding the use of noninvasive ventilation in acute respiratory failure
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept